Macular Degeneration Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with dry age-related macular degeneration (dry AMD), confirmed by the trial doctor
• People who are able to communicate clearly with the trial team and are willing and able to follow the study requirements
• People who have been fully informed about the study and have signed a written consent form agreeing to take part (people added to the study retrospectively will need to be contacted and sign a consent form before their data can be used)

Who may not be able to join:

• People who have signs, a history of, or currently have a type of macular degeneration involving abnormal blood vessel growth (sometimes called "wet" AMD or exudative macular neovascularization)
• People who have, or have had, a buildup of fluid in or under the retina for any reason, such as diabetic macular oedema, central serous retinopathy, or cystoid macular oedema
• People who have used any medication or treatment that makes the body sensitive to light (applied to the skin or injected) within 30 days before treatment, without first consulting their doctor, where that medication could be activated by the light device used in this trial
• People who are known to be sensitive to yellow light, red light, or near-infrared light, or who have a history of light-triggered conditions affecting the brain or nervous system, such as epilepsy or migraines
• People who, in the trial doctor's judgement, are unlikely to follow the study requirements, or have any condition that could interfere with their participation or that may not be in their best interest

Important: Always verify eligibility with the trial site directly before applying.